Objective. The purpose of this study was to investigate the efficacy of sonography in the detection of plantar fasciitis (PF) compared with magnetic resonance imaging (MRI) findings in subjects with inferior heel pain. Methods. Seventy-seven patients with unilateral (n = 9) and bilateral (n = 68) heel pain were studied. Seventy-seven age-and sex-matched asymptomatic subjects served as a control group. Magnetic resonance imaging was used to establish a diagnosis of PF with sagittal T1-weighted, T2-weighted, and short tau inversion recovery sequences. The sonographic appearances of PF were compared with MRI findings. Plantar fascia and heel pad thickness were also measured on both imaging modalities. Results. Compared with MRI, sonography showed 80% sensitivity and 88.5% specificity in assessing PF. A strong correlation was found between plantar fascia and fat pad thickness measurements done by sonography (P < .001; r = 0.854) and MRI (P < .001; r = 0.798). Compared with the asymptomatic volunteers, patients with PF had significant increases in plantar fascia and heel pad thicknesses, weight, and body mass index (P = .0001). Heel pad thickness was also significantly increased with pain duration (P = .021). Conclusions. Although MRI is the modality of choice in the morphologic assessment of different plantar fascia lesions, sonography can also serve as an effective tool and may substitute MRI in the diagnosis of PF.
Fat accumulation is more prominent in visceral and subcutaneous regions in PCOS. Increased BMI and abdominal type of obesity are closely related to the increased carotid artery IMT and insulin resistance. Weight control and regional weight loss are important part of the treatment for the future health of women with PCOS.
The EE-CA is an effective regimen in treatment of hirsutism and menstrual regulation. Although it provides significant decrease in subcutaneous fat thickness after 6-month treatment, it has no beneficial effect with respect to visceral fat thickness, metabolic and cardiovascular risk factors.
Thalassaemia major has important side effects on the hypothaloma-pituitary-gonadal axis resulting in pubertal and menstrual abnormalities. HRT should be given to provide normal sexual maturation in these patients.
Background: Congenital uterine anomalies are the most common form of female reproductive tract anomalies. The anomalies are classified into seven major categories in which unicornuate uterus is part of the class II group. Unicornuate uterus with a noncommunicating cavitary rudimentary horn in a young female may present with lower-quadrant tenderness, an abnormal mass, and cyclic or noncyclic pelvic pain that mimics acute appendicitis when localized in the right lower quadrant. Case: This article reports an unusual form of unicornuate uterus in a 14-year-old girl presenting with severe dysmenorrhea and right lower-quadrant tenderness. Abdominal ultrasonography revealed a small uterus and a hypoechogenic solid tubular right pelvic mass. Magnetic resonance imaging (MRI) showed a centrally cystic solid mass in the right pelvic region. Results: The mass was removed via laparotomy and proved to be a rudimentary horn separate from the uterus and bowel lying freely in the right lower quadrant. Conclusions: Uterine anomalies mimicking an acute abdomen as appendicitis must be kept in mind in postmenarchal young patients presenting with cyclic pelvic pain, lower quadrant tenderness, and an abnormal mass. MRI examination as a complement to ultrasound should be the imaging modality used to make the correct diagnosis. In cases of unicornuate uterus with a cavitary communicating or noncommunicating rudimentary horn, surgical removal of the rudimentary horn is indicated to avoid potential complications. ( J GYNECOL SURG 28:143)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.